These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18458905)

  • 1. Bone marrow transplant cure for beta-thalassaemia major: initial experience from a developing country.
    Ullah K; Khan B; Raza S; Ahmed P; Satti TM; Butt T; Tariq WZ; Kamal MK
    Ann Hematol; 2008 Aug; 87(8):655-61. PubMed ID: 18458905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant infections: single center experience from the developing world.
    Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant outcome in chronic myeloid leukaemia.
    Raza S; Ullah K; Ahmed P; Khan B; Kamal MK
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation in hematological disorders: single center experience from Pakistan.
    Ullah K; Ahmed P; Raza S; Satti T; Nisa Q; Mirza S; Akhtar F; Kamal MK; Akhtar FM
    Transplant Proc; 2007 Dec; 39(10):3347-57. PubMed ID: 18089384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome.
    Li CK; Shing MM; Chik KW; Lee V; Leung TF; Cheung AY; Yuen MP
    Bone Marrow Transplant; 2002 Jan; 29(2):101-5. PubMed ID: 11850702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
    Farzana T; Shamshi TS; Irfan M; Ansari SH; Baig MI; Shakoor N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
    Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of hematopoietic stem cell transplantation in children less than three years of age.
    Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
    Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood stem cell transplantation in children with beta-thalassemia.
    Yesilipek MA; Hazar V; Küpesiz A; Kizilörs A; Uguz A; Yegin O
    Bone Marrow Transplant; 2001 Dec; 28(11):1037-40. PubMed ID: 11781613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation in beta-thalassaemia--single centre study.
    Hashmi KU; Khan B; Ahmed P; Hussain I; Rasul S; Hanif E; Naeem M; Iqbal H; Malik HS
    J Pak Med Assoc; 2004 Oct; 54(10):499-503. PubMed ID: 15552281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
    Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
    Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
    Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
    Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
    Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
    Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
    Cheuk DK; Wang P; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
    Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.